Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the efficacy and safety of topical application of
tacrolimus for superficial Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA).